Pargyline Hydrochloride

N/A

Report date: 2022/05/25 17:50:41
NME

Base Information

Drug NamePargyline Hydrochloride
Drug Alias Name盐酸优降灵pargyline帕吉林pargilinapargylinum +[9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase B inhibitorsMonoamine oxidase A inhibitors
TargetsMonoamine oxidase AMonoamine oxidase B
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeC02KC01